Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1232-1240

  Stanwood, Gregg D ^a,b   Lucki, Irwin ^a   McGonigle, Paul ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 7 HYDROXY 2 (N,N PROPYL N 3' IODO 2' PROPENYL)AMINOTETRALIN; BACLOFEN; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IODINE 125; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 2,3 DIHYDRO 5 IODOBENZOFURAN 7 CARBOXAMIDE; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 5,6 DIMETHOXYSALICYLAMIDE; QUINPIROLE; RESERPINE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; DRUG RECEPTOR BINDING; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY;

ANIMALS; AUTORADIOGRAPHY; BACLOFEN; COCAINE; MALE; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RESERPINE; TETRAHYDRONAPHTHALENES;

EID: 0033680308     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice
2. 125I] autoradiography
3. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
4. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
5. 125I]iodosulpride
6. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain
7. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment
8. Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain
9. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors
10. Regulation and functional characterization of a rat recombinant dopamine D3 receptor
11. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens
12. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
13. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus
14. Effects of baclofen on nigral dopaminergic cell activity following acute and chronic haloperidol treatment
15. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia
16. Behavioral and neurochemical effects of continuous infusion of cocaine in rats
17. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning
18. Effects of haloperidol treatment on dopamine D2 and D3 receptor densities
19. The D3 dopamine receptor: Neurobiology and potential clinical relevance
20. 3H]-7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
21. Aminotetralin drugs and D3 receptor functions
22. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin
23. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons
24. Repeated 7-OH-DPAT treatments: Behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine
25. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors
26. In vivo occupancy of D2 and D3 receptors determined with EEDQ
27. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment
28. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats
29. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats
30. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: A key to receptor regulatory mechanisms
31. 3 receptor agonist
32. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ
33. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities
34. Molecular biology of dopamine receptors
35. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities
36. 125I]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals
37. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat
38. Effect of chronic treatment with selective agonists on the subtypes of dopamine receptors
39. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed energy control mechanism
40. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment
41. Dopamine D3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens
42. Up-regulation of D3 dopamine receptor mRNA by neuroleptics
43. The pharmacology of mesolimbic dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain
44. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice
45. Dopamine D3 receptor mutant and wold-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists